期刊文献+

阿托伐他汀对CHF患者血清胱抑素C、心肾及炎性指标的影响 被引量:3

Influence of Atorvastatin on Cystatin C,Heart and Renal Function,Inflammatory Indexes of Patients with Congestive Heart Failure
暂未订购
导出
摘要 目的探讨阿托伐他汀对充血性心衰(CHF)患者血清胱抑素C(CysC)、心肾及炎性指标的影响。方法选取2010年3月-2012年2月于南京市胸科医院进行治疗的58例充血性心衰患者为研究对象,将其根据随机数字表法分为对照组(常规治疗组)和观察组(阿托伐他汀组)每组各29例,将两组患者治疗前及治疗后4周、8周的血清CysC、心肾及炎性指标进行比较。结果观察组治疗后4周及8周的血清CysC及炎性指标均低于对照组,而心肾指标改善幅度也大于对照组,且治疗后8周上述指标均优于治疗后的4周,P均<0.05,差异均有统计学意义。结论阿托伐他汀可显著改善CHF患者CysC、心肾功能及炎性指标,可全面改善患者机体的综合状态。 Objective To study the influence of atorvastatin on the level of serum cystatin C(CysC),cardiac and renal function,inflammatory indexes of patients with congestive heart failure(CHF).Methods Total 58 patients with congestive heart failure in our hospital from March 2010 to February 2012 were selected as research object,and they were divided into control group(routine treatment group) and observation group(atorvastatin group) with 29 cases in each group according to random number table,then the serum CysC,cardiac and renal function,inflammatory indexes of two groups before and after the treatment at fourth and eighth week were compared.Results The serum CysC and inflammatory indexes of observation group after the treatment at fourth and eighth week were all lower than those of control group,improvement range of cardiac and renal function indexes were all bigger than those of control group,the difference were significant(P0.05).Conclusion The atorvastatin can significantly improve the CysC,cardiac and renal function,inflammatory indexes of patients with CHF,and its comprehensive application value is higher.
作者 陆治平 黄进
出处 《中华全科医学》 2013年第4期542-542,588,共2页 Chinese Journal of General Practice
关键词 阿托伐他汀 CHF CYSC 心肾功能 炎性指标 Atorvastatin Congestive heart failure Cystatin C Cardiac function and renal function Inflammatory indexes
  • 相关文献

参考文献10

二级参考文献64

共引文献79

同被引文献26

  • 1心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:568
  • 2陈元立,刘宗亮.急性冠脉综合征早期应用阿托伐他汀临床观察[J].赣南医学院学报,2007,27(3):435-436. 被引量:2
  • 3Arita Y, Kihara S, OuchiN, et al. Paradoxical decrease of an adipose- specific protein, adiponectin, in obesity [ J ]. Biochem Biophys Res Commun,1999,257( 1 ) :79-83.
  • 4Aikawa M, Rabkin E,Sugiyama S,et al. An HMG-CoA re- duetase inhibitor, cerivastatin, suppresses growth of maeroph- ages expressing matrix metalloproteinases and tissue factor in vivo and in vitro[ J ]. Circulation,2001,103:276-283.
  • 5Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent isehemic events in acute coro- nary syndromes: the MIRACL study: a randomized con- trolled triM[ J ]. JAMA ,200l ,285 : 1711 -1718.
  • 6Bustos C, Hernandez- Presa MA, Ortego M, et al. HMG- CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of artherosclerosis [ J ]. Am Coil Cardiol.1998 .32 :2057-2060.
  • 7Germano Di Sciascio,Giuseppe Patti,Vincenzo Pasceri,Achille Gaspardone,Giuseppe Colonna,Antonio Montinaro.Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention[J]. Journal of the American College of Cardiology . 2009 (6)
  • 8Carlo Briguori,Gabriella Visconti,Amelia Focaccio,Bruno Golia,Alaide Chieffo,Alfredo Castelli,Marco Mussardo,Matteo Montorfano,Bruno Ricciardelli,Antonio Colombo.Novel Approaches for Preventing or Limiting Events (Naples) II Trial[J]. Journal of the American College of Cardiology . 2009 (23)
  • 9Jing Tan,Qi Hua.Correlations between Serum Inflammation Factors and Left Ventricular Remodeling in Acute ST Segment Elevation Myocardial Infarction. Yonsei Medical Journal . 2012
  • 10Prasad A,Pratim Datta P,Roy R,et al.Comparative study of ezetimibe and atorvastatin alone and in combination on lipid profile in rats. Mater Sociomed . 2013

引证文献3

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部